Ovarian Cancer Clinical Trial

Digital Outreach Intervention for Lung Cancer Screening

Summary

mPATH-Lung (mobile Patient Technology for Health - Lung) is an innovative digital outreach program that identifies patients who qualify for lung cancer screening and helps them get screened. The study will: 1) Determine the effect of mPATH-Lung on receipt of lung cancer screening in a pragmatic randomized-controlled trial conducted with primary care patients in two large health networks, 2) Elucidate the drivers of patients' screening decisions and screening behavior; and 3) Explore implementation outcomes that will impact the sustainability and dissemination of mPATH-Lung using program data, surveys, and interviews.

This project will determine how mPATH-Lung affects patients' screening decisions and their completion of screening.

View Full Description

Full Description

Primary Objective: Determine the effectiveness of mPATH-Lung on receipt of LCS in a randomized pragmatic clinical trial of 1318 patients recruited from two large health networks, Wake Forest Baptist Health and the University of North Carolina at Chapel Hill.

Secondary Objectives:

Elucidate the drivers of patients' decisions to receive or forgo LCS through a values clarification exercise embedded within mPATH-Lung and supplemental semi-structured interviews of at least 50 patients.
Assess several critical implementation outcomes (reach, acceptability, and appropriateness) to inform the sustainability and scalability of mPATH-Lung across diverse primary care settings

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Meet the Medicare criteria for lung cancer screening, as updated in February 2022:

Age 50 - 77 years
Smoked at least 20 pack years
Current smoker or quit smoking within the past 15 years
Be scheduled to see a primary care provider within the health network in the next 3-4 weeks
Have a patient portal account or cellphone number listed in the electronic health record

Exclusion Criteria:

Patients flagged as needing a language interpreter in the electronic health record (electronic messages and intervention is delivered in English only).

Those for whom lung cancer screening would be inappropriate:

Prior history of lung cancer
Chest CT within the last 12 months
Those with medical conditions predicting shorter life expectancy
Patients whose home address is not within the state of North Carolina. (Due to telehealth guidelines)

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

1320

Study ID:

NCT04083859

Recruitment Status:

Recruiting

Sponsor:

Wake Forest University Health Sciences

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

University of North Carolina- Chapel Hill
Chapel Hill North Carolina, 27599, United States More Info
Jenna Minser
Contact
919-966-5905
[email protected]
Daniel Reuland, PhD
Principal Investigator
Alison Brenner, PhD
Sub-Investigator
Renee Ferrari, PhD
Sub-Investigator
Wake Forest Baptist Medical Center
Winston-Salem North Carolina, 27101, United States More Info
Elena Wright, MS
Contact
336-713-3103
[email protected]
David P Miller, MD, MS
Principal Investigator
Ajay Dharod, MD
Sub-Investigator
Christina Bellinger, MD
Sub-Investigator
Anna Snavely, PhD
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

1320

Study ID:

NCT04083859

Recruitment Status:

Recruiting

Sponsor:


Wake Forest University Health Sciences

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.